Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment.

Saved in:
Bibliographic Details
Title: Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment.
Authors: Li ZB; Senior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Chen DD; Department II of Infectious Diseases (Hepatology), The Second People's Hospital of Jingzhou City, Jingzhou, China., Jia YF; Department of Hepatobiliary & Gastrointestinal, Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, China., He QJ; Department II of Gastroenterology, The Eighth People's Hospital of Qingdao, Qingdao, China., Cui L; Department of Emergency, the Fifth Medical Center of PLA General Hospital, Beijing, China., Du FX; Department of Pharmacy, Medical Supplies Center of PLA General Hospital, Beijing, China., Kang YJ; Department of Medical Quality Management, the Fifth Medical Center of PLA General Hospital, Beijing, China., Feng X; Out-patient Department, Hospital of Beijing Information Science and Technology University, Beijing, China., He M; 302 Clinical Medical School, Peking University, Beijing, China., Jin XY; Department of Medical Quality Management, the Fifth Medical Center of PLA General Hospital, Beijing, China., Chen J; JCSchool of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Wang Y; Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong, Hong Kong SAR, China., Ji D; Senior Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, China.; 302 Clinical Medical School, Peking University, Beijing, China., Lau G; Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong, Hong Kong SAR, China., Wu SG; Out-patient Department, Hospital of Beijing Information Science and Technology University, Beijing, China.
Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Aug 07; Vol. 14, pp. 1413589. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2235-2988
DOI:10.3389/fcimb.2024.1413589